c-Abl regulates YAPY357 phosphorylation to activate endothelial atherogenic responses to disturbed flow

Local flow patterns determine the uneven distribution of atherosclerotic lesions. This research aims to elucidate the mechanism of regulation of nuclear translocation of Yes-associated protein (YAP) under oscillatory shear stress (OSS) in the atheroprone phenotype of endothelial cells (ECs). We report here that OSS led to tyrosine phosphorylation and strong, continuous nuclear translocation of YAP in ECs that is dependent on integrin &agr;5&bgr;1 activation. YAP overexpression in ECs blunted the anti-atheroprone effect of an integrin &agr;5&bgr;1–blocking peptide (ATN161) in Apoe–/– mice. Activation of integrin &agr;5&bgr;1 induced tyrosine, but not serine, phosphorylation of YAP in ECs. Blockage of integrin &agr;5&bgr;1 with ATN161 abolished the phosphorylation of YAP at Y357 induced by OSS. Mechanistic studies showed that c-Abl inhibitor attenuated the integrin &agr;5&bgr;1–induced YAP tyrosine phosphorylation. Furthermore, the phosphorylation of c-Abl and YAPY357 was significantly increased in ECs in atherosclerotic vessels of mice and in human plaques versus normal vessels. Finally, bosutinib, a tyrosine kinase inhibitor, markedly reduced the level of YAPY357 and the development of atherosclerosis in Apoe–/– mice. The c-Abl/YAPY357 pathway serves as a mechanism for the activation of integrin &agr;5&bgr;1 and the atherogenic phenotype of ECs in response to OSS, and provides a potential therapeutic strategy for atherogenesis.

[1]  D. Qi,et al.  c‐Abl tyrosine kinase regulates neutrophil crawling behavior under fluid shear stress via Rac/PAK/LIMK/cofilin signaling axis , 2018, Journal of cellular biochemistry.

[2]  Shuang He,et al.  Yes-Associated Protein Promotes Angiogenesis via Signal Transducer and Activator of Transcription 3 in Endothelial Cells , 2018, Circulation research.

[3]  Yu Huang,et al.  Integrin-YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow , 2016, Nature.

[4]  S. Chien,et al.  Flow-dependent YAP/TAZ activities regulate endothelial phenotypes and atherosclerosis , 2016, Proceedings of the National Academy of Sciences.

[5]  Daniel G. Anderson,et al.  Interaction between integrin α5 and PDE4D regulates endothelial inflammatory signalling , 2016, Nature Cell Biology.

[6]  S. Chien,et al.  Activation of integrin α5 mediated by flow requires its translocation to membrane lipid rafts in vascular endothelial cells , 2016, Proceedings of the National Academy of Sciences.

[7]  B. Hammock,et al.  Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration. , 2015, American journal of physiology. Heart and circulatory physiology.

[8]  Arif Yurdagul,et al.  αvβ3 Integrins Mediate Flow-Induced NF-κB Activation, Proinflammatory Gene Expression, and Early Atherogenic Inflammation. , 2015, The American journal of pathology.

[9]  Jay D. Humphrey,et al.  Mechanotransduction and extracellular matrix homeostasis , 2014, Nature Reviews Molecular Cell Biology.

[10]  S. Corbett,et al.  The fate of internalized α5 integrin is regulated by matrix-capable fibronectin. , 2014, The Journal of surgical research.

[11]  A. Mazar,et al.  &agr;5&bgr;1 Integrin Signaling Mediates Oxidized Low-Density Lipoprotein–Induced Inflammation and Early Atherosclerosis , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[12]  G. P. Studzinski,et al.  Non-receptor protein tyrosine kinases signaling pathways in normal and cancer cells , 2014, Critical reviews in clinical laboratory sciences.

[13]  H. Hurwitz,et al.  Dual inhibition of &agr;V integrins and Src kinase activity as a combination therapy strategy for colorectal cancer , 2013, Anti-cancer drugs.

[14]  M. Dontenwill,et al.  Integrin α5β1, the Fibronectin Receptor, as a Pertinent Therapeutic Target in Solid Tumors , 2013, Cancers.

[15]  T. Brümmendorf,et al.  Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: results from the BELA trial. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Gregory F Weber,et al.  Mechanical stress-activated integrin α5β1 induces opening of connexin 43 hemichannels , 2012, Proceedings of the National Academy of Sciences.

[17]  M. Ginsberg,et al.  Regulation of integrin activation. , 2011, Annual review of cell and developmental biology.

[18]  C. Bode,et al.  The Oral Spleen Tyrosine Kinase Inhibitor Fostamatinib Attenuates Inflammation and Atherogenesis in Low-Density Lipoprotein Receptor–Deficient Mice , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[19]  Nicola Elvassore,et al.  Role of YAP/TAZ in mechanotransduction , 2011, Nature.

[20]  Yi Fu,et al.  A Novel Mechanism of &ggr;/&dgr; T-Lymphocyte and Endothelial Activation by Shear Stress: The Role of Ecto-ATP Synthase &bgr; Chain , 2011, Circulation research.

[21]  B. Gelfand,et al.  Atheroprone Hemodynamics Regulate Fibronectin Deposition to Create Positive Feedback That Sustains Endothelial Inflammation , 2010, Circulation research.

[22]  Li Li,et al.  The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. , 2010, Genes & development.

[23]  Yi Fu,et al.  A Novel Mechanism of (cid:1) / (cid:2) T-Lymphocyte and Endothelial Activation by Shear Stress The Role of Ecto-ATP Synthase (cid:3) Chain , 2010 .

[24]  K. Guan,et al.  A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). , 2010, Genes & development.

[25]  V. Korshunov,et al.  Fibronectin Is an Important Regulator of Flow-Induced Vascular Remodeling , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[26]  P. Davies,et al.  Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology , 2009, Nature Clinical Practice Cardiovascular Medicine.

[27]  W. Schaper,et al.  Activation of the integrins α5β1 and αvβ3 and focal adhesion kinase (FAK) during arteriogenesis , 2008, Molecular and Cellular Biochemistry.

[28]  Kevin J. Cheung,et al.  Tumor Suppressor LATS1 Is a Negative Regulator of Oncogene YAP* , 2008, Journal of Biological Chemistry.

[29]  Y. Shaul,et al.  Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. , 2008, Molecular cell.

[30]  Y. Shaul,et al.  Yap 1 Phosphorylation by c-Abl Is a Critical Step in Selective Activation of Proapoptotic Genes in Response to DNA Damage , 2008 .

[31]  Li Li,et al.  Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. , 2007, Genes & development.

[32]  G. Feldmann,et al.  Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals , 2007, Cell.

[33]  Christopher Autry,et al.  Cellular Characterization of a Novel Focal Adhesion Kinase Inhibitor* , 2007, Journal of Biological Chemistry.

[34]  J. Balligand,et al.  NITRIC OXIDE-DEPENDENT ENDOTHELIAL FUNCTION AND CARDIOVASCULAR DISEASE , 2006, Acta clinica Belgica.

[35]  M. Schwartz,et al.  The subendothelial extracellular matrix modulates NF-κB activation by flow , 2005, The Journal of cell biology.

[36]  M. Schwartz,et al.  The subendothelial extracellular matrix modulates NF-kappaB activation by flow: a potential role in atherosclerosis. , 2005, The Journal of cell biology.

[37]  Giulio Superti‐Furga,et al.  c‐Abl is an effector of Src for growth factor‐induced c‐myc expression and DNA synthesis , 2002, The EMBO journal.

[38]  Dwayne G Stupack,et al.  ECM Remodeling Regulates Angiogenesis: Endothelial Integrins Look for New Ligands , 2002, Science's STKE.

[39]  M. Gishizky,et al.  SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling , 2000, Molecular and Cellular Biology.

[40]  A. Kazlauskas,et al.  c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. , 1999, Genes & development.

[41]  J. Schwarzbauer,et al.  Modulation of Cell‐Extracellular Matrix Interactions a , 1998, Annals of the New York Academy of Sciences.

[42]  R. Juliano,et al.  Integrin-mediated signaling events in human endothelial cells. , 1998, Molecular biology of the cell.

[43]  M. Schwartz,et al.  Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[44]  L. Cantley,et al.  Recognition and specificity in protein tyrosine kinase-mediated signalling. , 1995, Trends in biochemical sciences.

[45]  Charis Eng,et al.  Catalytic specificity of protein-tyrosine kinases is critical for selective signalling , 1995, Nature.